RESULTS FROM A PHASE 4, OPEN-LABEL, MULTICENTER, TWO-COHORT, TWO-PERIOD, SLOW-TITRATION AND FOOD EFFECT TRIAL TO ASSESS THE SAFETY AND EFFICACY OF XANOMELINE AND TROSPIUM CHLORIDE IN SCHIZOPHRENIA

Authors
Category Primary study
Conference64th Annual Meeting of the American College of Neuropsychopharmacology, ACNP 2026
Year 2026
This article has no abstract
Epistemonikos ID: c64cd3a6a8d14eba7eb9e0b04d0a12d906a726d0
First added on: Feb 07, 2026